Oligonucleotide API Market Analysis

  • Report ID: 4308
  • Published Date: Jun 24, 2024
  • Report Format: PDF, PPT

Oligonucleotide API Market Analysis

End-user (Pharmaceutical Companies, Biotechnology Companies)

The global oligonucleotide API market is segmented and analyzed for demand and supply by end-user into pharmaceutical companies and biotechnology companies. Among these two segments, the pharmaceutical companies segment is estimated to gain the largest market share over the projected time frame. The growth of the segment can be attributed to the increasing adoption of innovative technology by pharmaceutical giants for improving drug efficacy and reducing development costs. For instance, a variety of oligonucleotides has become increasingly popular in the pharmaceutical industry, including antisense oligonucleotides, short-interfering RNAs, splice-switching oligonucleotides, microRNAs, immunostimulatory oligonucleotides, aptamers. The capacity to target the illness gene or the messenger RNAs (mRNAs) that are encoded by it has created new therapeutic possibilities. The length of therapeutic antisense oligonucleotides (ASOs) varies from 18 to 30 base pairs (bp).

API type {Short Interfering RNA (siRNA), Antisense Oligonucleotides, Phosphorodiamidate Morpholino Oligonucleotides (PMO), Aptamers, CpG Oligonucleotides, MiRNA API}

The global oligonucleotide API market is also segmented and analyzed for demand and supply by type into short interfering RNA (siRNA), antisense oligonucleotides, phosphorodiamidate morpholino oligonucleotides (PMO), aptamers, CpG oligonucleotides, MiRNA API, and others. Amongst these segments, the antisense oligonucleotides segment is expected to garner a significant share. The growth of the segment can be attributed to the rising focus on personalized medicine across the globe, along with the high efficiency of antisense for delivering effective results in the treatment. Besides this, antisense oligonucleotides deliver effective outcomes in Alzheimer’s treatment. Thus, spiking cases of Alzheimer’s is another factor that is projected to boost the growth of the segment in coming years. This, as a result, is anticipated to create numerous opportunities for the growth of the segment in the coming years.

Our in-depth analysis of the global market includes the following segments:

                 By API Type

  • Short Interfering RNA (siRNA)
  • Antisense Oligonucleotides
  • Phosphorodiamidate Morpholino Oligonucleotides (PMO)
  • Aptamers
  • CpG Oligonucleotides
  • MiRNA API
  • Others

                By Marketing Status

  • Marketed
  • Clinical Trials

                By End User

  • Pharmaceutical Companies
  • Biotechnology Companies
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4308
  • Published Date: Jun 24, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of oligonucleotide api is assessed at USD 2.4 Billion.

The oligonucleotide api market size was over USD 2.19 Billion in 2023 and is anticipated to reach USD 7.21 Billion by the end of 2036, growing at around 9.6% CAGR during the forecast period i.e., between 2024-2036. Globally rising prevalence of cancer and neurodegenerative diseases, growth in percentage of API manufacturing facilities, and growing expenditures on healthcare throughout the world are the major factors driving the market growth.

North America is expected to hold majority industry share by 2036, attributed majorly to the increased healthcare spending, along with enhanced healthcare facilities in the region.

Ionis Pharmaceuticals, Inc, .Jazz Pharmaceuticals plc, BIOGEN INC., Sarepta Therapeutics, Inc., Alnylam Pharmaceuticals, Inc., Corden Pharma International GmbH, Nitto Denko Avecia, Inc., Merck KGaA, Ajinomoto Co., Inc., Kaneka Eurogentec S.A.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample